Drug-eluting stents - Cost versus clinical benefit

被引：79

作者：

Lemos, PA ^{[1
]}

Serruys, PW ^{[1
]}

Sousa, JE ^{[1
]}

机构：

[1] Erasmus Med Ctr, Thoraxctr, NL-3015 GD Rotterdam, Netherlands

来源：

CIRCULATION | 2003年 / 107卷 / 24期

关键词：

D O I：

10.1161/01.CIR.0000078025.19258.28

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：3003 / 3007

页数：5

共 23 条

[1] Coated scents for the prevention of restenosis: Part II [J].

Babapulle, MN ;

Eisenberg, MJ .

CIRCULATION, 2002, 106 (22) :2859-2866

[2]

De Scheerder I, 2002, CIRCULATION, V106, P394

[3] Sirolimus-eluting stent for treatment of complex in-stent restenosis - The first clinical experience [J].

Degertekin, M ;

Regar, E ;

Tanabe, K ;

Smits, PC ;

van der Giessen, WJ ;

Carlier, SG ;

de Feyter, P ;

Vos, J ;

Foley, DP ;

Ligthart, JMR ;

Popma, JJ ;

Serruys, PW .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (02) :184-189

[4] Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation - Long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up [J].

Degertekin, M ;

Serruys, PW ;

Foley, DP ;

Tanabe, K ;

Regar, E ;

Vos, J ;

Smits, PC ;

van der Giessen, WJ ;

van den Brand, M ;

de Feyter, P ;

Popma, JJ .

CIRCULATION, 2002, 106 (13) :1610-1613

[5] Randomized trial comparing intravenous nitroglycerin and heparin for treatment of unstable angina secondary to restenosis after coronary artery angioplasty [J].

Doucet, S ;

Malekianpour, M ;

Théroux, P ;

Bilodeau, L ;

Côté, G ;

de Guise, P ;

Dupuis, J ;

Joyal, M ;

Gosselin, G ;

Tanguay, JF ;

Juneau, M ;

Harel, F ;

Nattel, S ;

Tardif, JC ;

Lespérance, J .

CIRCULATION, 2000, 101 (09) :955-961

[6] Six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions [J].

Grube, E ;

Silber, S ;

Hauptmann, KE ;

Mueller, R ;

Buellesfeld, L ;

Gerckens, U ;

Russell, ME .

CIRCULATION, 2003, 107 (01) :38-42

[7] Early outcome after sirolimus-eluting stent implantation in patients with acute coronary syndromes - Insights from the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry [J].

Lemos, PA ;

Lee, CH ;

Degertekin, M ;

Saia, F ;

Tanabe, K ;

Arampatzis, CA ;

Hoye, A ;

van Duuren, M ;

Sianos, G ;

Smits, PC ;

de Feyter, P ;

van der Giessen, WJ ;

van Domburg, RT ;

Serruys, PW .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (11) :2093-2099

[8]

Leon MB, 2002, CIRCULATION, V106, P393

[9] First clinical experience with a paclitaxel derivate-eluting polymer stent system implantation for in-stent restenosis - Immediate and long-term clinical and angiographic outcome [J].

Liistro, F ;

Stankovic, G ;

Di Mario, C ;

Takagi, T ;

Chieffo, A ;

Moshiri, S ;

Montorfano, M ;

Carlino, M ;

Briguori, C ;

Pagnotta, P ;

Albiero, R ;

Corvaja, N ;

Colombo, A .

CIRCULATION, 2002, 105 (16) :1883-1886

[10] A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. [J].

Morice, M ;

Serruys, PW ;

Sousa, JE ;

Fajadet, J ;

Hayashi, EB ;

Perin, M ;

Colombo, A ;

Schuler, G ;

Barragan, P ;

Guagliumi, G ;

Molnar, F ;

Falotico, R .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (23) :1773-1780

← 1 2 3 →